Tumor biomarkers, the substances which are produced by tumors or the body's responses to
tumors during tumorigenesis and progression, have been demonstrated to possess critical …

The history of tumor biomarker discovery has been one of limited success. Population based
screens are few and of limited clinical usefulness. Biomarkers that are able to segregate …

Cancer biomarkers (CB) are biomolecules produced either by the tumor cells or by other
cells of the body in response to the tumor. Every cell type has its unique molecular signature …

Cancer is a disease that showcases great molecular diversity among many individuals.
Patients with the same clinically diagnosed cancer often vary in their response to the same …

Driven by the development of new techniques, such as DNA microarrays, mass
spectroscopy, tissue microarrays or protein chips, a large number of biomarkers have been …

The integration of cancer biomarkers into oncology has revolutionized cancer treatment,
yielding remarkable advancements in cancer therapeutics and the prognosis of cancer …

Abstract Development of cancer is a multistage process which includes many molecular
alterations. It is evinced that a single genetic alteration is often insufficient to lead to the …

Background: In many cancers, predictive factors are important for recognition of high-risk
patients and amongst individualizing treatment. The understanding of these mechanisms …

Diagnostic detection and measurement of cancer disease progression are essential
elements for successful cancer disease management. The early stages of cancer …

In this Special Issue of Cancers, the latest insights on biomarkers in cancers are presented
in 33 up-to-the-minute research papers and reviews summing up the tremendous progress …